With adequate cover by antitubercular drugs, reactivation and spread of tuberculosis can be avoided despite the use of cancericidal doses of radiation, and life can be prolonged for patients having both tuberculosis and pulmonary neoplasms. The author draws on 15 years of clinical experience to demonstrate that the traditional contraindication of irradiation in tuberculars no longer holds true.